The occurrence of contaminants of emerging concern (CECs) such as pharmaceutical compounds (PhACs) is becoming a major global issue due to the persistence, bioaccumulation, and toxicity of these pollutants. Human and animal consumption was recognized as the major sources for pharmaceutical pollution. Existent conventional treatment processes have shown low degradation efficiencies towards PhACs. In this regard, TiO2 based nanocomposite photocatalysis process has presented effective degradation towards PhACs. Operational parameters such as dopant content, catalyst loading, and initial pH were the major factors in the photocatalysis system. In this review, we discuss the recent studies that have employed TiO2 based nanocomposite for the degradation of PhACs. Future research recommendations have also been elaborated.
PHARMACEUTICAL COMPOUNDS
Over recent years, the appearance of micropollutants in the aquatic environment became a major worldwide disquiet. Micropollutants which are also termed as emerging contaminants (ECs), consist of different and various amount of anthropic and natural substances, including pharmaceuticals, personal care products, agrochemicals, steroid hormones, and drugs of abuse (Luo et al., 2014; Ribeiro et al., 2015) . Pharmaceutical compounds (PhACs) are chemical compounds that are used to diagnose, cure, and prevent the occurrence of diseases (Quesada et al., 2019) . Furthermore, PhACs can be defined as prescriptions obtained over the counter and veterinary drugs which are used to cure human and fauna (Ebele et al., 2017) . One of the significant issues with these substances is that they are commonly present in water bodies at low concentration, ranging from the nanogram to the microgram per liter, and each of these substances differs in their chemical nature, making their detection, analysis, and even removal from water and wastewater treatment plants a challenging quest (Luo et al., 2014) . Moreover, pharmaceutical compounds are developed to be biologically active and persistent in order to maintain their therapeutic activity in human and animals (Lee et al., 2017b) . Hence, they can escape conventional biological treatment processes. In addition, the physiochemical properties of pharmaceuticals, such as lipophilicity, polarity, volatility, adsorption properties, and persistence (Farré et al., 2011; Geissen et al., 2015; Lee et al., 2017b) , means that they are not completely and easily removed from by traditional water and wastewater treatment processes, which can induce the bioaccumulation of these compounds in the aquatic environment, causing negative effects towards to the aquatic organisms, environment, and the public health (Lee et al., 2017b; Ebele et al., 2017) . Various types of human medicines, such as antibiotics, synthetic hormones, statins, anti-inflammatories, and cytotoxins are continuously produced and consumed in large amounts, reaching thousands of tons per year (Quesada et al., 2019) . It has also been documented that approximately about 3000 different substances are being used as ingredients for the manufacturing of pharmaceuticals, including painkillers, antibiotics, β-blockers, lipid regulators, impotence drugs, and antidepressants (Rodriguez-Narvaez et al., 2017). As a result, numerous pharmaceuticals, such as paracetamol, carbamazepine, and caffeine, have been detected in the sewage effluents and river systems of Australia as well as New Zealand, at maximum concentrations of 7150 ng/L, 682 ng/L, and 3770 ng/L, respectively (Scott et al., 2014) . Moreover, several PhACs such as acetaminophen, cimetidine, and sulfamethoxazole, at concentration levels of 34.8, 281, and 26.9 ng/L have been reported in the surface water of Han River in Korea (Choi et al., 2008) .
The presence of PhACs in water compartments has raised significant concerns due to their potential risk on humans and the aquatic environment (Tran et al., 2018; Quesada et al., 2019) . Although the potential risks on human health and environment from direct exposure to pharmaceuticals residuals are very low, however, exposure to pharmaceuticals can indirectly impact the environment (Boxall, 2018) . In the case of acetaminophen (ACT), it has been reported that overdosing on ACT can cause potentially fatal liver damage and rare skin reactions such as Steven-Johnson syndrome (Thi and Lee, 2017) . Furthermore, the existence of antibiotics, such as tetracycline, ampicillin, and trimethoprim in the aquatic environment, could potentially create antibiotic-resistant strains in the natural bacteria population (Ebele et al., 2017) . Moreover, pharmaceuticals, such as ciprofloxacin, oxolinic acid, and fluoroquinolone have been reported to cause adverse effects on aquatic organisms, such as toxicity towards green algae (Halling-Sørensen et al., 2000) , Daphnia magna, Microcystis aeruginosa, etc. (Robinson et al., 2005; Ebele et al., 2017) . In addition, antibiotics such as tetracycline have shown to cause toxic effects towards the plants as well as on the aquatic organisms in their early stage (Lee et al., 2017b) . Existence of pharmaceuticals in the aquatic environment has also been found to prompt endocrine or hormonal disruption problems (Khataee et al., 2013 ). An experimental study conducted by Kidd et al. (2007) in a pristine lake in Canada, revealed that addition of some pharmaceuticals such as estrogen ethinyl estradiol (EE2) can potentially induce the feminization of males and can cause the collapse of the fish population. As a consequence, several approaches have been adopted in the USA, United Kingdom, and Australia, in order to assess the health risks resulting from exposure to pharmaceuticals in water (WHO, 2012) . According to the World Health Organization (WHO), the potential health risks from pharmaceuticals in drinking water can be assessed by employing the minimum therapeutic dose (MTD) as the selected point of departure (PoD) (Watts and Maycock, 2007; WHO, 2012) . The MTD, is usually equal to the recommended or lowest prescribed dose, taking into account the number of daily doses. Another approach, which is based on ranking the pharmaceuticals and personal care products (PPCPs) according to their relative potential risk on the aquatic environment has also been adopted by the Environmental Agency (EA) of England and Wales (Ebele et al., 2017) . The proposed ranking system employs a conventional risk assessment procedures, namely as: persistence, bioaccumulation, and toxicity (PBT). Based on these criteria, top compounds that can pose potential risk were identified (Ashton et al., 2004; Ebele et al., 2017) . In spite of the fact that there are no legal discharge limits for emerging contaminates, however, some regulations have been issued (Barbosa et al., 2016) . For example, the European water policy has published the first regulation "Directive 2000/60/EC", which uses a strategy that prioritizes substances that can pose high risks (Directive, 2000) . Eight years later, a group of 33 priority substances and respective environmental quality standards (EQS) were regulated by the Directive 2008/105/EC (Directive, 2008) . Followed by the new Directive 2013/39/EC that recommended the monitoring and treatment for another set of 45 substances (Directive, 2013) . Recently, it has been reported that the standard environmental regulation permits a maximum total pharmaceutical waste concentration of only 50 ng/L in discharge water (Rosman et al., 2018).
Fate and occurrence of pharmaceuticals
Although the growth rate of the financial disbursement per person of pharmaceutical compounds (PhACs) has declined. However, due to the decrease in the production cost and development of generic drugs, the price for PhACs became more affordable and accessible. Subsequently, the consumption rate has steadily increased in recent years. Furthermore, the continuous demand for the treatment of common illnesses, such as chronic diseases and aging disorders has also contributed to the increasing consumption in pharmaceuticals (Quesada et al., 2019) . The routes and fates of pharmaceutical compounds have been discussed in several literatures (Rosman et al., 2018; Lee et al., 2017b; Quesada et al., 2019) . Fig. 1 depicts the possible fate and pathways for the occurrence of pharmaceutical compounds in the aquatic environment. Generally, PhACs are introduced into the aquatic environment either in their parent form or as metabolites form via various routes. As shown in Fig. 1 , pharmaceutical residuals can be discharged and enter the surface water, groundwater, and soil via human and animal excretion after their consumption and metabolism. Basically, healthcare facilities, including hospitals and clinics, as well as private households, are considered among the major sources of pharmaceutical pollution. Hospitals contribute to major release of pharmaceuticals to the environment through patients' excretions (Bagheri et al., 2016) . This is followed by private household consumption of pharmaceuticals. Human excreted residue (feces and urines) may then enter sewage treatment plants (STPs) either in their parent compound or metabolite (Helwig et al., 2016) . Depending on the STPs and properties of pharmaceuticals, only parts of the PhACs are treated, whereas the remaining residues are introduced into the aquatic environment (Lee et al., 2017b), such as surface and ground water. In contrast, improper waste disposal of pharmaceuticals by human into toilets or sinks can also result in contamination of the environment (Lee et al., 2017b) . In addition, medicinal products for veterinary use are also considered a significant source of pharmaceutical pollution (Lee et al., 2017b) . Numerous drugs for veterinary are used in husbandry sector, mainly as growth promoters, breeding, and therapeutic purposes (Bundschuh et al., 2016) . After the consumption of pharmaceuticals by animals and livestock, pharmaceuticals are then excreted through feces and urines, either in their parent or metabolite form. The excreted drugs can then enter the soil and groundwater, causing contamination towards the environment (Lee et al., 2017b) . Moreover, livestock's manure, which is often used as a fertilizer in the agriculture industry, can sometimes contain pharmaceutical residues that could be introduced into surface water or groundwater through infiltration The occurrence of pharmaceutical compounds in water bodies is raising significant concerns as it's becoming a global issue. However, determining the global consumption of pharmaceuticals is of great difficulty. This is due to the fact that the number of compounds used differ locally, depending on the lifestyles, accessibility, location, and population (Quesada et al., 2019) . Table 1 summarizes some of the frequent detected pharmaceutical compounds in different countries. From Table 1 , it can be noticed that acetaminophen (paracetamol), which is often used as a painkiller, or for the treatment of headaches and fevers, showed the highest concentration among the other PhACs. This could be attributed to the popularity of this compound and because of its lower risk of gastrointestinal toxicity (e.g., ulceration, bleeding) and so may be better tolerated ( 
Removal of pharmaceuticals
Biological treatment technologies including activated sludge, constructed wetlands, aerobic bioreactor, trickling filter, membrane bioreactor (MBR), etc. are considered the most widely used treatment technologies for the removal of emerging contaminants (ECs), mainly, by the mechanism of biodegradation (Ahmed et al., 2017). The biodegradation mechanism is a process by which ECs are decomposed by microorganisms such as, bacteria, fungi, and algae, to simple inorganic matter, such as carbon dioxide and water (Garcia-Rodríguez et al., 2014). In the case of traditional biodegradation process, microorganisms employ organic matter as essential substrates for their growth and promotion of enzymes for their ingestion ( ) have stated that the use of activated sludge is more efficient and cheaper than the trickling filter. It has been reported that activated sludge treatment resulted in higher removal efficiency of over 85%, compared to less than 70% removal rate when using trickling filter as the treatment system. As a result, in order to employ such treatment technologies, the present biological systems should be developed and modified to be able to degrade persistent micropollutants (Ahmed et al., 2017) . Also, another disadvantage of using biological treatment systems is that they are very slow, and they contribute to the disposal of large quantities of sludge. Moreover, they require proper control over the temperature and the pH of the system (Ollis and Al-Ekabi, 1993; Kumar and Pandey, 2017). Furthermore, conventional wastewater treatment technologies are fashioned to degrade a variety of pollutants, such as carbonaceous matter, pathogens, nutrient, and particulates (Luo et al., 2014) . However, they are insufficient for the removal and degradation of micropollutants such as pharmaceuticals. Due to this fact, conventional treatment processes are sometimes considered the major route for the occurrence of pharmaceuticals in the environment (Lee et al., 2017b) . It is worth to mention that, biological or chemical reactions that occur in the secondary clarifiers of conventional wastewater treatment plants (WWTPs) can result in the generation and accumulation of by-products (Oulton et al., 2010) . As a result, some pharmaceutical compounds can exist in higher concentrations at the effluents of WWTPs than in the respective influents, which is attributed to the PhACs excretion as conjugates in the WWTPs. Generally, these released conjugates are metabolized during the biological treatment process and the origin compounds is emitted, which often results in increasing the concentration of the parent compound(s) at the effluent of WWTPs ( 
Advanced oxidation processes for the removal of pharmaceuticals
Among the treatment technologies used for the removal of pharmaceuticals, advanced oxidation processes (AOPs) are considered the most effective processes as they present a significant potential for the treatment of a wide variety of emerging contaminants. The AOPs involves the in-situ generation of the highly reactive oxygen species (ROS), as well as hydroxyl radicals (•OH), hydrogen peroxides (H2O2), O3, and superoxide anion radicals (O •-2). These generated oxidants can provide complete mineralization of the micro-pollutants to CO2, H2O, and organic ions or acids (Dalrymple et al., 2007; Kanakaraju et al., 2018) . In recent years, various advanced oxidation processes have been employed and investigated for the removal of several pharmaceuticals. Table 2 summarizes some of the latest publications that investigated the use of advanced oxidation processes for the removal of pharmaceuticals from contaminated water. Retention coefficients in municipal secondary effluent were higher than those obtained with ultrapure water, due to adsorption of hydrophobic compounds on the NOM of the secondary effluent or by the formation of the cake layer. 
HETEROGENEOUS PHOTOCATALYSIS AS AN ADVANCED OXIDATION PROCESS
Heterogeneous photocatalysis is an appealing low-temperature and pressure technology for its promising applications in the area of solar energy, green chemistry, and environmental remediation (Bellardita et al., 2018) . The potential of harnessing photocatalysis for the treatment of water was first discovered in 1972 by (Fujishima and Honda, 1972) which was founded based on the photo-electrochemical water splitting by using titania as the semiconductor catalyst. Photocatalysis may be defined as the acceleration of a photoreaction in the presence of a catalyst. Heterogeneous photocatalysis, in most cases, is referred to as "semiconductor photocatalysis" (Mills and Le Hunte, 1997; Singh et al., 2018). The photocatalytic oxidation is considered one of the advanced oxidation processes (AOPs) and certainly one of the most promising (AOPs) for the treatment of wastewater containing toxic and unbiodegradable substances such as pharmaceuticals (PhACs) and dyes. Heterogeneous photocatalysis oxidation is beneficial for the removal of hazardous and non-hazardous contaminates and persistent organic micropollutants in water and wastewater (Qu et al., 2013) . Numerous studies have investigated the employment of heterogeneous photocatalysis for the degradation and removal of various persistent pollutants and emerging contaminants of concern (ECC) such as, endocrine disrupting compounds (EDCs) ( . This is attributed to the fact that anatase exhibits higher conduction band (ECB) energy of (~0.2 eV). The high (ECB) of anatase and (ECB) position can affect the electron transfer rate and hence the charge recombination rate (Khaki et al., 2017) and because of the higher specific surface area (SSA) of anatase. However, this may result in higher recombination rate. Thence, the presence of rutile phase is recommended to lower and minimize the electron-hole recombination which results in higher photocatalytic activity (Hoffmann et al., 1995) . In addition, the higher photocatalytic activity of anatase is related to its slightly higher Fermi level and a higher degree of hydroxylation (generation of hydroxyl groups) (Mital and Manoj, 2011). However, it may be concluded that it is not a necessity that the anatase phase has a higher photocatalytic activity over the rutile phase. Serpone et al. (1996) and Tryba et al. (2017) reported that the type of the substrate employed in the treatment process can also influence the photocatalytic activity of anatase and rutile. It is noteworthy that the rutile structure also has a smaller band gap than the anatase structure which can improve the photocatalytic activity of the catalyst. Table 3 presents some of the studies that employed bare TiO2 as a photocatalyst for the degradation of pharmaceutical compounds. It can be noted from Table 3 , that the findings from these investigations were related to obtaining the optimum operating parameters to yield the highest removal rate of pharmaceuticals. In addition, one can notice that these investigations were focused on the degradation of pharmaceuticals in synthetic conditions (not real wastewater). However, due to the difference in optimum operating parameters between these studies, we observe that further studies on optimizing the operational parameters are required. Additionally, more studies on the degradation of pharmaceuticals in real wastewater conditions using bare TiO2 photocatalyst are also recommended.
TITANIUM DIOXIDE (TiO2) AS A PHOTOCATALYST

Drawbacks of TiO2 as a photocatalyst
Although titanium dioxide is an ideal photocatalyst for the degradation of pharmaceutical compounds and other micro-pollutants. However, the use of a single bare photocatalyst is associated with some drawbacks that hinder its use on a wide scale. These drawbacks include: (i) rapid recombination rate for the photo- Furthermore, the recombination of generated charge carries is considered another major limitation when using bare TiO2 catalyst. Basically, when the photogenerated electron-hole pair recombines, the excited electrons will return to the valence band (VB) without reacting with absorbed contaminates on the surface 
NANOCOMPOSITE MATERIALS
Nanocomposite materials are considered as solid structures with nanometer-scale dimensional distances between the various phases that comprise the structure. Typically, nanocomposites are formed by the coupling of two or more different materials at the nanoscale size into a matrix that constitutes of inorganic/organic standard materials in order to properly control and develop new and enhanced structures and properties. Hence, nanocomposite materials can consist of at least two phases which might include: an amorphous phase and a crystalline phase, or two crystalline phases. Generally, the properties of the nanocomposite materials depend on the individual characteristics of the matrix components as well as on the morphology and interfacial features (Ajayan et al., 2006; Öchsner et al., 2009 ). The photocatalytic degradation of contaminants in the presence of nanocomposite catalysts based on the heterogeneous photocatalysis process has been shown to have significant potential as an effective, low-cost, and environmentally sustainable advanced technology for the purification of contaminated water (Pawar and Lee, 2015) . Several studies have discussed the design and As discussed previously, using titania as a bare catalyst is associated with some drawbacks. The major drawback is related to the wide bandgap of TiO2 (3.2 eV) which hinders its activation to only under wavelengths located in the UV region (λ < 400 nm). Thus, it has been reported that doping and/or coupling metal oxides with TiO2 can significantly enhance the optical and structural properties of titanium dioxide by extending the light absorption of titania from the UV to the visible region (Zaleska, 2008) , hence improving its photocatalytic activity under visible light. The improvement in the optical properties of TiO2 nanocomposite is ascribed by the new energy level in the band gap of TiO2 matrix (Zaleska, 2008) . As illustrated in Fig. 3 , electrons are excited from the defect state to the conduction band (CB) of TiO2 by photons having energy equal or larger than hv2.
In addition, doping metal oxides with TiO2 matrix can noticeably enhance interfacial electron transfer rates, promote electron-hole trapping, and decrease recombination of electron-hole pairs (Zaleska, 2008; Gupta and Tripathi, 2011; Khaki et al., 2017) . Doping TiO2 with transition metals (i.e., Fe, Mo, and V) can also extend the spectral response of titania into the visible light spectrum, which improve its photocatalytic activity (Murakami et al., 2010; Pelaez et al., 2012) . This is because transition metal can supply additional energy level in the band gap of TiO2. Hence, the electron transfer from one of the new additional energy levels to the conduction band requires lesser photon energy than the undoped semiconductor (Gupta and Tripathi, 2011) . Doping and (or) coupling with noble metals (i.e., Ag, Au, and Pt) also improves the photocatalytic activity of TiO2 nanocomposite under visible light irradiations. This explained by the electron trapping and enhanced interfacial charge transfer, which inhibits electron-hole pairs recombination (You et al., 2005b; Pelaez et al., 2012) . Furthermore, doping titania with non-metallic materials (anions) has also been reported to shift the valence band edge of TiO2 upwards as shown in Fig. 3 , and thus narrowing the energy bandgap of TiO2, which is attributed to the mixing between the p states of anions with the 2p states of O atoms (Ni et al., 2007; Gupta and Tripathi, 2011; Bignozzi, 2011) . Fig. 3 . Mechanism of TiO2 photocatalysis: hv1: pure TiO2; hv2: metal-doped TiO2 and hv3: non-metal-doped TiO2 (Zaleska, 2008) In the past five years, several authors have investigated the photodegradation of various pharmaceutical compounds using TiO2 based nanocomposite photocatalysts. Moreover, they concluded that the photocatalytic activity was influenced by light intensity, irradiation time, and type of photocatalyst. They also observed that the major degradation by-products generated were 4-acetamidocatechol, 4acetamidoresorcinol, and hydroquinone. In the case of UV and solar irradiations, the proposed mechanism was predominated by hydroxyl radicals (OH) attack into the aromatic ring. The photodegradation of acetaminophen under visible light was further investigated by using WO3/TiO2 nanocomposites. Namshah and Mohamed (2018) successfully coupled tungsten oxide-transition metal into the structure of TiO2 nanowires via the sol-gel method. Their results showed that WO3/TiO2 with 3wt.% of WO3 fully degraded AP. This was ascribed to the improvements in optical properties and delay in e -/h + recombination rate. The synthesized nanocomposite exhibited excellent stability for the degradation of AP after five times. Further, the improvements in the optical properties of WO3/TiO2 nanocomposites can be explained by the electrons generated from the valence band (VB) of TiO2 to its conduction band (CB), and since the CB level of tungsten (+0.475) is higher than the CB level of TiO2 (-0.29) in the nanocomposite matrix, this would result in trapping the excited electron from the conduction band of titania by WO3. The photocatalytic degradation of other pharmaceutical compounds such as ketoprofen, ibuprofen, tetracycline, amoxicillin, and naproxen have also been investigated using titania-based nanocomposites ( Table 4 ). For instance, the photo-degradation of carbamazepine (CBZ), which is anti-epileptic drug used in the treatment of epilepsy been studied using graphene-TiO2-P25 nanocomposite catalyst under UV-A radiations. The degradation efficiency of CBZ was found to be affected by the graphene content in the titania lattice. The optimum weight percentage of graphene was 1.5Gr, as it yielded the best removal efficiency for CBZ (Appavoo et al., 2014) .
From Table 4 , one can notice that the degradation of pharmaceutical compounds was very effective by using TiO2 based nanocomposite catalyst. In addition, the synthesized nanocomposites exhibited enhanced structural and optical properties compared to the bare TiO2 photocatalyst. Further, it was shown in the majority of these investigations that the reusability of the nanocomposites was possible, even after several trials. Last, it is noteworthy that the dopant content in the TiO2 lattice and other operating parameters played a major in the degradation of these pharmaceuticals. 
CONCLUSIONS
Pharmaceuticals have been detected in wastewater effluents as well as in other water sources and even in drinking water. The appearance of pharmaceuticals is mainly due to their physiochemical properties, which hinder their natural biodegradation. The major route for the occurrence of pharmaceuticals in the aquatic environment was related to the insufficiency of conventional wastewater treatment processes. Present conventional wastewater treatment processes cannot fully degrade PhACs. As a result, numerous advanced oxidation technologies (AOTs) have been developed. Photocatalysis based on titanium dioxide showed a promising future for the degradation of pharmaceuticals. TiO2 photocatalysis has several advantages over the AOTs, such as the ability to fully degrade pharmaceuticals, low-cost, and recovery as well as reusability of the photocatalyst. However, using TiO2 as a bare catalyst is associated with some drawbacks that hinder its application on a wide scale. Several researchers have fabricated and developed numerous nanocomposite catalysts based on TiO2. The novel synthesized TiO2 based nanocomposites exhibited enhanced optical and structural properties. Most important, the ability to utilize the nanocomposite catalysts under visible light and solar irradiations, rendering it more environmentally friendly, sustainable, and effective for the degradation of pharmaceuticals. Another advantage was the possibility to reuse the nanocomposite for several times. Because of the many factors that can affect the photodegradation of pharmaceuticals, such as dopant content, catalyst loading, initial pH, etc. and because of the various pharmaceuticals that exist in the aquatic environment, additional studies are required to obtain the optimum conditions for the degradation of PhACs. In addition, more studies regarding the mineralization of the pharmaceuticals is also required using TiO2 based nanocomposite. Furthermore, the review above leads us to the fact that more pilot-scale and largescale studies and investigations are required to test the degradation of various pharmaceuticals under real conditions using practical and cheap TiO2 based nanocomposite photocatalysts.
